vs

Side-by-side financial comparison of Forian Inc. (FORA) and RAPID MICRO BIOSYSTEMS, INC. (RPID). Click either name above to swap in a different company.

RAPID MICRO BIOSYSTEMS, INC. is the larger business by last-quarter revenue ($11.3M vs $8.0M, roughly 1.4× Forian Inc.). Forian Inc. runs the higher net margin — -22.9% vs -110.8%, a 87.9% gap on every dollar of revenue. On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs 37.0%). Over the past eight quarters, RAPID MICRO BIOSYSTEMS, INC.'s revenue compounded faster (41.8% CAGR vs 27.8%).

Forian Inc is a specialized healthcare technology and data analytics firm offering SaaS-based real-world evidence solutions, clinical decision support tools, and operational optimization services. It serves biopharmaceutical companies, healthcare providers, and life sciences stakeholders to improve patient outcomes, accelerate research, and boost care delivery efficiency.

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

FORA vs RPID — Head-to-Head

Bigger by revenue
RPID
RPID
1.4× larger
RPID
$11.3M
$8.0M
FORA
Growing faster (revenue YoY)
RPID
RPID
+0.3% gap
RPID
37.3%
37.0%
FORA
Higher net margin
FORA
FORA
87.9% more per $
FORA
-22.9%
-110.8%
RPID
Faster 2-yr revenue CAGR
RPID
RPID
Annualised
RPID
41.8%
27.8%
FORA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FORA
FORA
RPID
RPID
Revenue
$8.0M
$11.3M
Net Profit
$-1.8M
$-12.5M
Gross Margin
49.2%
Operating Margin
-24.4%
-108.2%
Net Margin
-22.9%
-110.8%
Revenue YoY
37.0%
37.3%
Net Profit YoY
-1012.2%
-29.3%
EPS (diluted)
$-0.06
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FORA
FORA
RPID
RPID
Q4 25
$8.0M
$11.3M
Q3 25
$7.8M
$7.8M
Q2 25
$7.5M
$7.3M
Q1 25
$7.1M
$7.2M
Q4 24
$5.8M
$8.2M
Q3 24
$4.7M
$7.6M
Q2 24
$4.8M
$6.6M
Q1 24
$4.9M
$5.6M
Net Profit
FORA
FORA
RPID
RPID
Q4 25
$-1.8M
$-12.5M
Q3 25
$-151.2K
$-11.5M
Q2 25
$224.8K
$-11.9M
Q1 25
$-1.1M
$-11.3M
Q4 24
$199.7K
$-9.7M
Q3 24
$-204.9K
$-11.3M
Q2 24
$-2.6M
$-12.6M
Q1 24
$-1.2M
$-13.3M
Gross Margin
FORA
FORA
RPID
RPID
Q4 25
49.2%
Q3 25
51.6%
Q2 25
56.8%
Q1 25
55.6%
Q4 24
58.3%
Q3 24
70.1%
Q2 24
62.2%
Q1 24
65.1%
Operating Margin
FORA
FORA
RPID
RPID
Q4 25
-24.4%
-108.2%
Q3 25
-6.1%
-145.1%
Q2 25
0.6%
-167.3%
Q1 25
-19.8%
-161.8%
Q4 24
-24.9%
-124.5%
Q3 24
-17.0%
-158.3%
Q2 24
-62.2%
-202.1%
Q1 24
-36.3%
-254.4%
Net Margin
FORA
FORA
RPID
RPID
Q4 25
-22.9%
-110.8%
Q3 25
-1.9%
-146.8%
Q2 25
3.0%
-163.3%
Q1 25
-16.0%
-156.3%
Q4 24
3.4%
-117.6%
Q3 24
-4.4%
-148.9%
Q2 24
-53.4%
-190.1%
Q1 24
-24.9%
-237.4%
EPS (diluted)
FORA
FORA
RPID
RPID
Q4 25
$-0.06
$-0.26
Q3 25
$0.00
$-0.26
Q2 25
$0.01
$-0.27
Q1 25
$-0.04
$-0.26
Q4 24
$0.01
$-0.22
Q3 24
$-0.01
$-0.26
Q2 24
$-0.08
$-0.29
Q1 24
$-0.04
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FORA
FORA
RPID
RPID
Cash + ST InvestmentsLiquidity on hand
$31.6M
$20.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$29.8M
$33.2M
Total Assets
$44.1M
$74.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FORA
FORA
RPID
RPID
Q4 25
$31.6M
$20.0M
Q3 25
$28.2M
$18.9M
Q2 25
$35.6M
$18.3M
Q1 25
$35.7M
$18.9M
Q4 24
$35.1M
$16.9M
Q3 24
$49.4M
$22.0M
Q2 24
$48.0M
$37.1M
Q1 24
$47.4M
$22.4M
Stockholders' Equity
FORA
FORA
RPID
RPID
Q4 25
$29.8M
$33.2M
Q3 25
$31.1M
$44.3M
Q2 25
$30.9M
$54.5M
Q1 25
$30.0M
$65.5M
Q4 24
$30.1M
$75.4M
Q3 24
$28.4M
$84.4M
Q2 24
$27.2M
$94.6M
Q1 24
$28.1M
$105.9M
Total Assets
FORA
FORA
RPID
RPID
Q4 25
$44.1M
$74.9M
Q3 25
$41.3M
$84.4M
Q2 25
$48.5M
$75.6M
Q1 25
$48.6M
$85.4M
Q4 24
$47.2M
$98.2M
Q3 24
$57.5M
$105.8M
Q2 24
$58.4M
$117.1M
Q1 24
$57.5M
$127.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FORA
FORA
RPID
RPID
Operating Cash FlowLast quarter
$3.2M
$-3.2M
Free Cash FlowOCF − Capex
$-3.3M
FCF MarginFCF / Revenue
-29.6%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-31.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FORA
FORA
RPID
RPID
Q4 25
$3.2M
$-3.2M
Q3 25
$-439.7K
$-9.1M
Q2 25
$-344.5K
$-9.7M
Q1 25
$448.2K
$-9.1M
Q4 24
$1.7M
$-9.9M
Q3 24
$764.1K
$-8.6M
Q2 24
$-23.1K
$-10.1M
Q1 24
$-2.2M
$-15.5M
Free Cash Flow
FORA
FORA
RPID
RPID
Q4 25
$-3.3M
Q3 25
$-9.1M
Q2 25
$-10.1M
Q1 25
$-9.4M
Q4 24
$-10.0M
Q3 24
$-8.8M
Q2 24
$-10.6M
Q1 24
$-16.1M
FCF Margin
FORA
FORA
RPID
RPID
Q4 25
-29.6%
Q3 25
-116.4%
Q2 25
-138.6%
Q1 25
-130.2%
Q4 24
-121.8%
Q3 24
-116.0%
Q2 24
-159.8%
Q1 24
-287.1%
Capex Intensity
FORA
FORA
RPID
RPID
Q4 25
0.8%
Q3 25
0.9%
Q2 25
5.0%
Q1 25
4.4%
Q4 24
0.0%
1.2%
Q3 24
0.0%
2.9%
Q2 24
0.0%
6.9%
Q1 24
0.0%
10.4%
Cash Conversion
FORA
FORA
RPID
RPID
Q4 25
Q3 25
Q2 25
-1.53×
Q1 25
Q4 24
8.76×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FORA
FORA

Financial Services Revenues$7.3M92%
Other$669.0K8%

RPID
RPID

Products$9.3M83%
Services$2.0M17%

Related Comparisons